Nuvation Bio Inc.
NUVBNYSECIK 1811063HealthcareFiscal year ends Dec 31
Reports and events: 103 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0607:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336751 |
| 2026-08-0606:55 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336646 |
| 2026-07-0617:15 ET | 8-K | 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-296398 |
| 2026-06-3017:17 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-290823 |
| 2026-05-2716:16 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-241922 |
| 2026-05-0416:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-204056 |
| 2026-05-0416:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-203964 |
| 2026-04-1011:23 ET | DEF 14A | Proxy statementPeriod 2026-05-21 | 0001140361-26-014157 |
| 2026-03-0216:49 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-085584 |
| 2026-03-0216:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-085474 |
| 2026-01-1208:07 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009826 |
| 2025-11-2608:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-298551 |
| 2025-11-1717:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-284845 |
| 2025-11-0316:22 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-262605 |
| 2025-11-0316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-262576 |
| 2025-08-0709:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104626 |
| 2025-08-0707:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174954 |
| 2025-06-1116:24 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-139164 |
| 2025-05-2314:21 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-125763 |
| 2025-05-0716:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065712 |
| 2025-05-0716:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-114908 |
| 2025-04-0816:45 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001140361-25-012864 |
| 2025-03-2509:05 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-062031 |
| 2025-03-0617:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-034903 |
| 2025-03-0617:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-048529 |
| 2025-03-0516:04 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-25-047165 |
| 2025-03-0416:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-25-045568 |
| 2025-02-1216:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-025099 |
| 2024-11-0616:43 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-252153 |
| 2024-11-0616:41 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122402 |
| 2024-10-1816:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-239642 |
| 2024-10-0716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-233794 |
| 2024-09-1016:51 ET | SC 13D | Ownership report, active investor | 0001104659-24-098630 |
| 2024-09-0516:35 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-24-214241 |
| 2024-08-0508:44 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-090347 |
| 2024-08-0508:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-193412 |
| 2024-07-3016:01 ET | DEF 14A | Proxy statementPeriod 2024-09-03 | 0001193125-24-188838 |
| 2024-06-2017:26 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-164595 |
| 2024-05-1416:28 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-059622 |
| 2024-05-1416:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-138263 |
| 2024-04-2616:13 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0000950170-24-049137 |
| 2024-04-1016:06 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-091875 |
| 2024-03-2620:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-077868 |
| 2024-03-2507:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-075908 |
| 2024-02-2917:06 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023247 |
| 2024-02-2916:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-053575 |
| 2024-01-0816:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-004426 |
| 2023-12-1416:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295446 |
| 2023-11-2716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-283346 |
| 2023-11-1316:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-276021 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.